** Coloplast's COLOb.CO shares rise around 3% after its Q4 margin came in above expectations
** Jefferies says Coloplast delivered "solid" set of results, noting a "strong" margin beat at 28.0% and organic sales growth of 7%, matching expectations
** "COLOB remains a key pick thanks to sector-leading growth profile, reset expectations, no tariff exposure and appealing valuation," it adds
** Tuesday's rise reduces the stock's YTD losses to about 24%
(Reporting by Agnieszka Gosciak-Rabalska)
((agnieszka.gosciak@thomsonreuters.com; +48 58 769 66 00;))